 | Up a level |
Trapp, Christian; Aebersold, Daniel M; Belka, Claus; Casuscelli, Jozefina; Emmett, Louise; Eze, Chukwuka; Fanti, Stefano; Farolfi, Andrea; Fendler, Wolfgang; Grosu, Anca-Ligia; Guckenberger, Matthias; Hruby, George; Kirste, Simon; Koerber, Stefan A; Kroeze, Stephanie; Peeken, Jan C; Rogowski, Paul; Scharl, Sophia; Shelan, Mohamed; Spohn, Simon K B; ... (2024). Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis. European journal of nuclear medicine and molecular imaging, 51(12), pp. 3770-3781. Springer 10.1007/s00259-024-06802-x
Shelan, Mohamed; Achard, Vérane; Appiagyei, Felix; Mose, Lucas; Zilli, Thomas; Fankhauser, Christian D; Zamboglou, Constantinos; Mohamad, Osama; Aebersold, Daniel M; Cathomas, Richard (2024). Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases, 27(3), pp. 422-431. Nature 10.1038/s41391-024-00829-9
Mohamad, Osama; Li, Yun Rose; Feng, Felix; Hong, Julian C; Wong, Anthony; El Kouzi, Zakaria; Shelan, Mohamed; Zilli, Thomas; Carroll, Peter; Roach, Mack (2024). Delayed definitive management of localized prostate cancer: what do we know? (In Press). Prostate cancer and prostatic diseases Nature 10.1038/s41391-024-00876-2
Pahud de Mortanges, Aurélie; Luo, Haozhe; Shu, Shelley Zixin; Kamath, Amith; Suter, Yannick; Shelan, Mohamed; Pöllinger, Alexander; Reyes, Mauricio (2024). Orchestrating explainable artificial intelligence for multimodal and longitudinal data in medical imaging. NPJ digital medicine, 7(1) Nature Publishing Group 10.1038/s41746-024-01190-w
Gómez-Aparicio, María Antonia; López-Campos, Fernando; Buchser, David; Lazo, Antonio; Willisch, Patricia; Ocanto, Abrahams; Sargos, Paul; Shelan, Mohamed; Couñago, Felipe (2024). Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers, 16(13) MDPI AG 10.3390/cancers16132331
Ost, Piet; Siva, Shankar; Brabrand, Sigmund; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Shelan, Mohamed; Conde-Moreno, Antonio; López Campos, Fernando; Papachristofilou, Alexandros; Guckenberger, Matthias; Scorsetti, Marta; Zapatero, Almudena; Villafranca Iturre, Ana-Elena; Eito, Clara; Couñago, Felipe; Muto, Paolo; Van De Voorde, Lien; ... (2024). PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. European urology oncology, 7(3), pp. 462-468. Elsevier 10.1016/j.euo.2023.09.007
Scharl, Sophia; Zamboglou, Constantinos; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Koerber, Stefan A; Debus, Jürgen; Peeken, Jan C; Vogel, Marco M E; Kroeze, Stephanie G C; Guckenberger, Matthias; Krafcsik, Manuel; Hruby, George; Emmett, Louise; Schmidt-Hegemann, Nina-Sophie; Trapp, Christian; Spohn, Simon K B; Henkenberens, Christoph; Mayer, Benjamin; Shelan, Mohamed; ... (2024). European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 194, p. 110215. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2024.110215
Shelan, Mohamed; Aebersold, Daniel Matthias (May 2024). PSMA-PET/CT improves outcomes after salvage radiotherapy for recurrent prostate cancer after surgery. Radiotherapy and oncology, 194(S1), S2297-S2298. Elsevier
Aebersold, Daniel Matthias; Shelan, Mohamed (May 2024). Whole vs. hemi pelvis RT in patients with PSMA-positive nodal recurrence - a retrospective analysis. Radiotherapy and oncology, 194(S1), S2436-S2438. Elsevier
Shelan, Mohamed; Mose, Lucas; Ahmadsei, Maiwand; Aebersold, Daniel Matthias (May 2024). Salvage Radiotherapy after Failure of Primary Focal Therapy for prostate cancer:A Systematic Review. Radiotherapy and oncology, 194(Supplement), S2614-S2615. Elsevier
Shelan, Mohamed; Aebersold, Daniel Matthias (May 2024). [High-5-jD] Die European Association of Urology Risikogruppen Einteilung liefert eine zuverlässige Vorhersage für das BPFS und MFS bei Patienten, die eine PSMA-PET geplante salvage Strahlentherapie bei einem biochemischen Rezidiv eines Prostatakarzinoms erhalten. Strahlentherapie und Onkologie, S9-S9. Springer
Mohamad, Osama; Zamboglou, Constantinos; Zilli, Thomas; Murthy, Vedang; Aebersold, Daniel M; Loblaw, Andrew; Guckenberger, Matthias; Shelan, Mohamed (2024). Safety of ultra-hypofractionated pelvic nodal irradiation in the definitive management of prostate cancer: Systematic Review and Meta-analysis. International journal of radiation oncology, biology, physics, 118(4), pp. 998-1010. Elsevier 10.1016/j.ijrobp.2023.09.053
Mohamad, Osama; Nicosia, Luca; Mathier, Etienne; Riggenbach, Elena; Zamboglou, Constantinos; Aebersold, Daniel M; Alongi, Fillipo; Shelan, Mohamed (2024). Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis. Brachytherapy, 23(3), pp. 309-320. Elsevier 10.1016/j.brachy.2024.01.011
Windisch, Paul; Becker, Ivo; Tang, Hongjian; Schröder, Christina; Buchali, André; Aebersold, Daniel M; Zwahlen, Daniel R; Förster, Robert; Shelan, Mohamed (2024). Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation. BMC urology, 24(1), p. 28. BMC 10.1186/s12894-024-01421-y
Mathier, Etienne; Althaus, Alexander; Zwahlen, Daniel; Lustenberger, Jens; Zamboglou, Constantinos; De Bari, Berardino; Aebersold, Daniel M; Guckenberger, Matthias; Zilli, Thomas; Shelan, Mohamed (2024). HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol. BMJ open, 14(e075846) BMJ Publishing Group 10.1136/bmjopen-2023-075846
Sabbagh, Ali; Tilki, Derya; Feng, Jean; Huland, Hartwig; Graefen, Markus; Wiegel, Thomas; Böhmer, Dirk; Hong, Julian C; Valdes, Gilmer; Cowan, Janet E; Cooperberg, Matthew; Feng, Felix Y; Mohammad, Tarek; Shelan, Mohamed; D'Amico, Anthony V; Carroll, Peter R; Mohamad, Osama (2024). Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. European urology focus, 10(1), pp. 66-74. Elsevier 10.1016/j.euf.2023.07.004
Adebahr, Sonja; Althaus, Alexander; Scharl, Sophia; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Lanzafame, Helena; Trapp, Christian; Koerber, Stefan A; Peeken, Jan C; Vogel, Marco M E; Vrachimis, Alexis; Spohn, Simon K B; Grosu, Anca-Ligia; Kroeze, Stephanie G C; Guckenberger, Matthias; Fanti, Stefano; Hruby, George; Emmett, Louise; Belka, Claus; ... (2024). The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy. European journal of nuclear medicine and molecular imaging, 51(2), pp. 558-567. Springer 10.1007/s00259-023-06438-3
Schröder, Christina; Mose, Lucas; Mathier, Etienne; Zwahlen, Daniel Rudolf; Aebersold, Daniel Matthias; Förster, Robert; Shelan, Mohamed (2023). Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers, 15(24) MDPI AG 10.3390/cancers15245815
Shelan, Mohamed; Mohamad, Osama; Nicosia, Luca; Mathier, Etienne; Riggenbach, Elena; Zamboglou, Constantinos; Alongi, Filippo; Aebersold, D. M. (18 September 2023). Focal brachytherapy as definitive treatment for localized prostate cancer: a systematic review and meta-analysis. Strahlentherapie und Onkologie, 11(199), p. 1044. Springer
Shelan, Mohamed; Krcek, Reinhardt; Mackeprang, Paul-Henry; Schmidhalter, Daniel (September 2023). Dosimetric impact of hydrogel spacer implantation in re-irradiation for intra-prostatic recurrence: a case study. Strahlentherapie und Onkologie, 11. Springer
Shelan, Mohamed; Zilli, Thomas; Aebersold, D. M. (September 2023). Safety of ultra-hypofractionated pelvic nodal irradiation for high risk prostate cancer patients: systematic review and metaanalysis. Strahlentherapie und Onkologie, 11(199), pp. 1048-1049. Springer
Shelan, Mohamed; Janbain, Ali; Armelle, Arnoux; Aebersold, D. M.; Schael, Sophia (September 2023). Random survival forest model for predicting biochemical outcome of salvage radiotherapy after radical prostatectomy. Strahlentherapie und Onkologie, 11(199), p. 1050. Springer
Windisch, Paul; Becker, Ivo; Schröder, Christina; Buchali, André; Zwahlen, Daniel R.; Förster, Robert; Shelan, Mohamed (September 2023). Calculating the international prostate symptom score (IPSS) using the expanded prostate cancer index composite (EPIC) urinary subscales: modeling and external validation. Strahlentherapie und Onkologie, 11(199), p. 1052. Springer
Solomonidou, Nantia; Germanou, Daphnie; Strouthos, Iosif; Karagiannis, Efstratios; Farolfi, Andrea; Koerber, Stefan A; Debus, Juergen; Peeken, Jan C; Vogel, Marco E; Vrachimis, Alexis; Spohn, Simon K B; Shelan, Mohamed; Aebersold, Daniel; Grosu, Anca-Ligia; Ceci, Francesco; Kroeze, Stephanie G C; Guckenberger, Matthias; Fanti, Stefano; Belka, Claus; Hruby, George; ... (2023). PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. European journal of nuclear medicine and molecular imaging, 50(8), pp. 2529-2536. Springer 10.1007/s00259-023-06185-5
Scharl, Sophia; Zamboglou, Constantinos; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Lanzafame, Helena; Giuseppe Morganti, Alessio; Trapp, Christian; Koerber, Stefan A; Debus, Jürgen; Peeken, Jan C; Vogel, Marco M E; Vrachimis, Alexis; K B Spohn, Simon; Ruf, Juri; Grosu, Anca-Ligia; Ceci, Francesco; Fendler, Wolfgang P; Bartenstein, Peter; Kroeze, Stephanie G C; ... (2023). Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 184, p. 109678. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.109678
Krcek, Reinhardt; Shelan, Mohamed (2023). [Hyaluronic acid spacers for optimizing rectal dose in hypofractionated radiotherapy of the prostate]. Strahlentherapie und Onkologie, 199(7), pp. 692-693. Springer 10.1007/s00066-023-02088-4
Hanke, Luca; Tang, Hongjian; Schröder, Christina; Windisch, Paul; Kudura, Ken; Shelan, Mohamed; Buchali, André; Bodis, Stephan; Förster, Robert; Zwahlen, Daniel R (2023). Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed. Cancers, 15(13) MDPI AG 10.3390/cancers15133454
Shelan, Mohamed (14 June 2023). [VS02-1] Entwicklung und Validierung eines prädiktiven Nomogrammes für die PSMA-PET-basierte Salvage Strahlentherapie bei rezidiviertem Prostatakarzinom. Strahlentherapie und Onkologie, 199(S1), S11-S12. Springer
Shelan, Mohamed; Aebersold, Daniel Matthias (14 June 2023). [P20-8-jD] Effektivität der Salvage-Strahlentherapie (SRT) bei Patienten mit PSMA-PET-negativem biochemischem Progress – Ergebnisse einer retrospektiven Studie. Strahlentherapie und Onkologie, 199(S1), S155-S156. Springer
Archer, Paul; Marvaso, Giulia; Detti, Beatrice; Colombo, Francesca; Francolini, Giulio; Vandendorpe, Benjamin; Thananayagam, Marie Albert; Baty, Manon; De Crevoisier, Renaud; Alongi, Filippo; Nicosia, Luca; Scher, Nathaniel; Toledano, Alain; Di Muzio, Nadia; Fodor, Andrei; Zilli, Thomas; Franzese, Ciro; Scorsetti, Marta; Shelan, Mohamed; Triggiani, Luca; ... (2023). Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study. European urology oncology, 6(3), pp. 303-310. Elsevier 10.1016/j.euo.2023.03.005
Frech, Lukas Peter; Anschütz, Lukas Peter; Schubert, Adrian; Bojaxhiu, Beat; Aebersold, Daniel Matthias; Eliçin, Olgun; Shelan, Mohamed; Giger, Roland (June 2023). Loco-regional Control after Primary Surgery Compared to Chemo-Radiotherapy in Advanced Stage Laryngeal Cancer (Unpublished). In: SGORL Kongress (Schweizerische Gesellschaft für Oto-Rhino-Laryngologie, Hals- und Gesichtschirurgie). Zürich. 09.06.2023.
Zamboglou, Constantinos; Peeken, Jan C; Janbain, Ali; Katsahian, Sandrine; Strouthos, Iosif; Ferentinos, Konstantinos; Farolfi, Andrea; Koerber, Stefan A; Debus, Juergen; Vogel, Marco E; Combs, Stephanie E; Vrachimis, Alexis; Morganti, Alessio Giuseppe; Spohn, Simon K B; Shelan, Mohamed; Aebersold, Daniel M; Grosu, Anca-Ligia; Ceci, Francesco; Henkenberens, Christoph; Kroeze, Stephanie G C; ... (2023). Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer. JAMA Network Open, 6(5), e2314748. American Medical Association 10.1001/jamanetworkopen.2023.14748
Shelan, Mohamed (May 2023). OC-0435 Multi-institutional nomogram for PSMA-PET based salvage radiotherapy in recurrent prostate cancer. Radiotherapy and oncology, 182(S1), S335-S335. Elsevier
Mathier, Etienne; Dervishi, Gezim; Althaus, Alexander Maria Georg; Schanne, Daniel Hendrik; Aebersold, Daniel Matthias; Shelan, Mohamed (17 January 2023). Risk of bleeding following robotic stereotactic body radiation therapy in patients with localized prostate cancer in patients receiving baseline anticoagulant or antiplateletherapy. Strahlentherapie und Onkologie, p. 225. Springer
Shelan, Mohamed; Althaus, Alexander Maria Georg; Mathier, Etienne; Schanne, Daniel Hendrik; Aebersold, Daniel Matthias (17 January 2023). Biochemical control after robotic stereotactic body radiation therapy for unfavorable intermediate and high-risk prostate cancer: a single institutional experience with mid-term followup. Strahlentherapie und Onkologie, p. 225. Springer
Shelan, Mohamed; Anschuetz, Lukas; Schubert, Adrian; Bojaxhiu, Beat; Aebersold, Daniel M; Eliçin, Olgun; Giger, Roland (2023). Superior loco-regional control after primary surgery compared to chemo-radiotherapy for advanced stage laryngeal cancer. Frontiers in oncology, 13(1132486), p. 1132486. Frontiers Research Foundation 10.3389/fonc.2023.1132486
Schröder, Christina; Mose, Lucas; Förster, Robert; Mathier, Etienne; Zwahlen, Daniel R.; Aebersold, D. M.; Shelan, Mohamed (2023). Five fractions versus seven fractions SBRT for intermediate and high risk prostate cancer: a propensity score matched pair analysis. Strahlentherapie und Onkologie, 11(199), p. 1049. Springer
Hanke, Luca; Schröder, Christina; Windisch, Paul; Tang, Hongjian; Shelan, Mohamed; Zwahlen, Daniel R.; Förster, Robert (2023). "Dose-volume histogram parameters and quality-of-life in patients with prostate cancer treated with surgery and high-dose volumetric intensity-modulated arc therapy to the prostate bed". Strahlentherapie und Onkologie, 11(199), p. 1052. Springer
Shelan, Mohamed; Zimmermann, Frank; Guckenberger, Matthias; Aebersold, Daniel M. (2023). Ultra-hypofraktionierte stereotaktische Strahlentherapie beim Prostatakarzinom. Swiss medical forum(47), pp. 1450-1451. EMH Schweizerischer Ärzteverlag AG 10.4414/smf.2023.1270631050
Reinhardt, Philipp; Giger, Roland; Seifert, Eberhard; Shelan, Mohamed; Riggenbach, Elena; Terribilini, Dario; Joosten, Andreas; Schanne, Daniel H; Aebersold, Daniel M; Manser, Peter; Dettmer, Matthias S; Simon, Christian; Ozsahin, Esat M; Moeckli, Raphaël; Limacher, Andreas; Caparrotti, Francesca; Nair, Deepa; Bourhis, Jean; Broglie, Martina A; Al-Mamgani, Abrahim; ... (2022). VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial [study protocol]. Trials, 23(1), p. 906. BioMed Central 10.1186/s13063-022-06841-5
Mathier, Etienne; Heusel, Astrid; Shelan, Mohamed (2022). [Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials]. Strahlentherapie und Onkologie, 198(10), pp. 962-965. Springer 10.1007/s00066-022-01968-5
Bojaxhiu, Beat; Sinovcic, Dubravko; Eliçin, Olgun; Templeton, Arnoud J; Shelan, Mohamed; Wartenberg, Jan; Alberts, Ian; Rominger, Axel; Aebersold, Daniel M; Zaugg, Kathrin (2022). Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer. Radiation oncology, 17(1), p. 141. BioMed Central 10.1186/s13014-022-02112-4
Achard, Vérane; Jaccard, Maud; Vanhoutte, Frederik; Siva, Shankar; Heikkilä, Reino; Dirix, Piet; Liefhooghe, Nick; Otte, François-Xavier; Gomez-Iturriaga, Alfonso; Berghen, Charlien; Shelan, Mohamed; Conde-Moreno, Antonio; Campos, Fernando López; Papachristofilou, Alexandros; Guckenberger, Matthias; Meersschout, Sabine; Putora, Paul Martin; Zwahlen, Daniel; Couñago, Felipe; Scorsetti, Marta; ... (2022). Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 172, pp. 1-9. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2022.04.020
Eliçin, Olgun; Vollnberg, Bernd; Shelan, Mohamed; Riggenbach, Elena; Bojaxhiu, Beat; Mathier, Etienne; Giger, Roland; Aebersold, Daniel M.; Klaeser, Bernd (2021). Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer. Clinical and translational radiation oncology, 31, pp. 8-13. Elsevier 10.1016/j.ctro.2021.08.007
Shelan, Mohamed; Aebersold, Daniel M.; Albrecht, Clemens; Böhmer, Dirk; Flentje, Michael; Ganswindt, Ute; Höcht, Stefan; Hölscher, Tobias; Müller, Arndt-Christian; Niehoff, Peter; Pinkawa, Michael; Schmidt-Hegemann, Nina-Sophie; Sedlmayer, Felix; Wolf, Frank; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas; Ghadjar, Pirus (2021). Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO). Strahlentherapie und Onkologie, 197(11), pp. 993-1000. Springer 10.1007/s00066-021-01820-2
Shelan, Mohamed; Riggenbach, Elena; Aebersold, Daniel M. (2021). [Virtual prostatectomy using single dose radiotherapy]. Strahlentherapie und Onkologie, 197(10), pp. 943-945. Springer 10.1007/s00066-021-01824-y
Hemmatazad, Hossein; Mathier, Etienne; Aebersold, Daniel M.; Shelan, Mohamed (2021). [Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial]. Strahlentherapie und Onkologie, 197(9), pp. 859-861. Springer 10.1007/s00066-021-01806-0
Jereczek-Fossa, Barbara A; Marvaso, Giulia; Zaffaroni, Mattia; Gugliandolo, Simone Giovanni; Zerini, Dario; Corso, Federica; Gandini, Sara; Alongi, Filippo; Bossi, Alberto; Cornford, Philip; De Bari, Berardino; Fonteyne, Valérie; Hoskin, Peter; Pieters, Bradley R; Tree, Alison C; Arcangeli, Stefano; Fuller, Donald B; Franzese, Ciro; Hannoun-Levi, Jean-Michel; Janoray, Guillaume; ... (2021). Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus. Cancer treatment reviews, 98, p. 102206. Elsevier 10.1016/j.ctrv.2021.102206
Visini, Miranda; Giger, Roland; Shelan, Mohamed; Eliçin, Olgun; Anschuetz, Lukas (2021). Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer. The Laryngoscope, 131(5), E1543-E1549. Wiley 10.1002/lary.29186
Eliçin, Olgun; Koller Brolese, Eliane; Bojaxhiu, Beat; Sermaxhaj, Burim; Schanne, Daniel Hendrik; Mathier, Etienne; Lippmann, Jana; Shelan, Mohamed; Eller, Yannick; Aebersold, Daniel Matthias; Giger, Roland; Cihoric, Nikola (2021). The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer. Radiotherapy and oncology, 158, pp. 293-299. Elsevier 10.1016/j.radonc.2021.04.004
Koller Brolese, Eliane; Cihoric, Nikola; Bojaxhiu, Beat; Sermaxhaj, Burim; Schanne, Daniel Hendrik; Mathier, Etienne; Lippmann, Jana; Shelan, Mohamed; Eller, Yannick; Aebersold, Daniel M.; Giger, Roland; Eliçin, Olgun (2021). The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden. Radiotherapy and oncology, 158, pp. 162-166. Elsevier 10.1016/j.radonc.2021.02.039
Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gomez-Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Shelan, Mohamed; Mercier, Carole; Achard, Vérane; Thon, Kristian; Stellamans, Karin; Moon, Daniel; Conde-Moreno, Antonio; Papachristofilou, Alexandros; Scorsetti, Marta; Gückenberger, Matthias; Ameye, Filip; Zapatero, Almudena; ... (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European urology focus, 7(2), pp. 241-244. Elsevier 10.1016/j.euf.2020.12.010
Bojaxhiu, Beat; Shrestha, Binaya Kumar; Luterbacher, Pascal; Eliçin, Olgun; Shelan, Mohamed; Macpherson, Andrew J. S.; Heimgartner, Benjamin; Giger, Roland; Aebersold, Daniel; Zaugg, Kathrin (2020). Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy. Radiation oncology, 15(1), p. 281. BioMed Central 10.1186/s13014-020-01727-9
Bojaxhiu, Beat; Shrestha, Binaya Kumar; Luterbacher, Pascal; Eliçin, Olgun; Shelan, Mohamed; Macpherson, Andrew J. S.; Heimgartner, Benjamin; Giger, Roland; Aebersold, Daniel; Zaugg, Kathrin (2020). Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy Research Square 10.21203/rs.3.rs-60161/v2
Anschütz, Lukas; Shelan, Mohamed; Dematté, Marco; Schubert, Adrian D; Giger, Roland; Eliçin, Olgun (2019). Long-term functional outcome after laryngeal cancer treatment. Radiation oncology, 14(1), p. 101. BioMed Central 10.1186/s13014-019-1299-8
Eliçin, Olgun; Sermaxhaj, Burim; Bojaxhiu, Beat; Shelan, Mohamed; Giger, Roland; Rauch, Daniel; Aebersold, Daniel (2019). Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients. Strahlentherapie und Onkologie, 195(6), pp. 468-474. Springer 10.1007/s00066-018-1400-5
Shelan, Mohamed; Odermatt, Seline; Bojaxhiu, Beat; Nguyen, Daniel P; Thalmann, George; Aebersold, Daniel; Dal Pra, Alan (2019). Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy. Frontiers in oncology, 9(12), p. 12. Frontiers Research Foundation 10.3389/fonc.2019.00012
Eliçin, Olgun; Ermis, Ekin; Oehler, Christoph; Aebersold, Daniel M.; Caparrotti, Francesca; Zimmermann, Frank; Studer, Gabriela; Henke, Guido; Adam, Lukas; Anschütz, Lukas; Ozsahin, Mahmut; Guckenberger, Matthias; Shelan, Mohamed; Kaydıhan, Nuri; Riesterer, Oliver; Prestwich, Robin J D; Spielmann, Thierry; Giger, Roland; Şen, Mehmet (2019). Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study. Frontiers in oncology, 9(932), p. 932. Frontiers Research Foundation 10.3389/fonc.2019.00932
Bojaxhiu, Beat; Templeton, Arnoud J; Eliçin, Olgun; Shelan, Mohamed; Zaugg, Kathrin; Walser, Marc; Giger, Roland; Aebersold, Daniel; Dal Pra, Alan (2018). Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Radiation oncology, 13(1), p. 216. BioMed Central 10.1186/s13014-018-1159-y
Anschütz, Lukas; Visini, Miranda; Shelan, Mohamed; Eliçin, Olgun; Giger, Roland (2018). Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation. Head & neck - journal for the sciences and specialties of the head and neck, 40(11), pp. 2469-2475. J. Wiley 10.1002/hed.25373
Buergy, Daniel; Sertdemir, Metin; Weidner, Anja; Shelan, Mohamed; Lohr, Frank; Wenz, Frederik; Schoenberg, Stefan O; Attenberger, Ulrike I (2018). Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning? In Vivo, 32(1), pp. 125-131. International Institute of Anticancer Research (IIAR) 10.21873/invivo.11214
Cihoric, Nikola; Tsikkinis, Alexandros; Vlaskou Badra, Eugenia; Glatzer, Markus; Novak, Urban; Scherz, Amina; Shelan, Mohamed; Soldatovic, Ivan; Chittazhathu Kurian Kuruvilla, Yojena; Aebersold, Daniel; Lössl, Kristina (2017). Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiation oncology, 12(1), p. 202. BioMed Central 10.1186/s13014-017-0938-1
Shelan, Mohamed; Anschuetz, Lukas; Schubert, Adrian D; Bojaxhiu, Beat; Dal Pra, Alan; Behrensmeier, Frank; Aebersold, Daniel; Giger, Roland; Eliçin, Olgun (2017). T1-2 glottic cancer treated with radiotherapy and/or surgery. Strahlentherapie und Onkologie, 193(12), pp. 995-1004. Springer-Medizin-Verlag 10.1007/s00066-017-1139-4
Eliçin, Olgun; Terribilini, Dario; Shelan, Mohamed; Volken, Werner; Mathier, Etienne; Dal Pra, Alan; Aebersold, Daniel; Fix, Michael; Manser, Peter (2017). Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg? Radiation oncology, 12(1), p. 102. BioMed Central 10.1186/s13014-017-0838-4
